• Facebook
  • LinkedIn
  • Twitter

maltawinds.comLogo

The Economy's Voice

Menu

Skip to content
  • Home
  • About
  • Local News
  • International News
  • Opinion
  • Demia on Sundays
  • Demeter
  • Business
  • Satire on Sunday
  • Tourism, Hospitality and Travel – Yesterday, Today and Tomorrow
  • Russian scientists say Sputnik V performs well against COVID mutations

EU hit by delay to Oxford/AstraZeneca vaccine delivery

Posted by Vento on 23rd January 2021 in International News

Pharmaceutical group says initial volumes will ‘be lower than originally anticipated’

AstraZeneca has warned EU countries to expect significant shortfalls to early deliveries of its coronavirus vaccine, in a fresh blow to the rollout of the bloc’s immunisation programme, European officials have said.  The EU was expecting 100m doses of the jab in the first quarter of the year.

But people with knowledge of the discussions said the company may fail to deliver even half that amount, although they stressed that final figures had not been established. AstraZeneca insisted there was no “scheduled delay” to the start of shipments of its vaccines, but said “initial volumes” would “be lower than originally anticipated due to reduced yields at a manufacturing site within our European supply chain”.

“We will be supplying tens of millions of doses in February and March to the EU, as we continue to ramp up production volumes,” the company said, adding that the change in expected volumes did not affect the UK. Details of the revised first-quarter deliveries to the EU were still being worked out but they could be less than 40m, several European officials said. Part of the reason for the uncertainty is that the provisional timetables are dependent on when the vaccine receives regulatory approval, which could happen next week.

It was “not looking good in the short term” for AstraZeneca jab supplies, one European official said. A second described the proposed shortfall as “significant” while another branded it a “disgrace”, reflecting the growing frustration in Europe over problems with the Covid-19 immunisation programme.

Stella Kyriakides, the EU’s health commissioner, tweeted that AstraZeneca representatives had announced the delays in a steering committee meeting with the European Commission and member states on the bloc’s vaccine strategy. “@EUCommission and Member States expressed deep dissatisfaction with this. We insisted on a precise delivery schedule on the basis of which Member States should be planning their vaccination programs, subject to the granting of a conditional marketing authorisation,” she wrote.

And Norway, which is not in the EU, said late on Friday evening that it would receive fewer than 200,000 doses of the AstraZeneca vaccine in February, well below the 1.12m it had been expecting. Camilla Stoltenberg, head of the Norwegian Institute of Public Health, said to receive less than 18 per cent of the promised doses was a “disappointment” and showed that vaccine deliveries were “extremely uncertain”. 

The news of delays is particularly problematic for EU countries because they have placed a big bet on the AstraZeneca jab and are gearing up for what they hope is its imminent regulatory approval. The vaccine, made in collaboration with Oxford university, was the first pre-ordered by the European bloc and the up to 400m doses of the two-shot course would cover almost half the region’s 446m population. 

The interruption will add to growing anxiety around EU member states over the slow start to Covid-19 inoculation compared with some other rich countries, notably the US and UK. The concerns have been amplified this week as EU nations tighten travel rules in response to fears over the spread of highly transmissible coronavirus variants identified in the UK and elsewhere.  This month EU governments criticised Pfizer’s decision to cut temporarily supplies of the vaccine it developed with BioNTech to European countries. The company insists the supply will be made up later and the move will help it increase production later in the year.

The UK is the only country in Europe to have approved the AstraZeneca jab, which has helped British health authorities ramp up their vaccination programme. US approval is not expected until April, US health authorities have said. The vaccine has proved contentious after observers questioned the integrity of trial data that underpinned efficacy figures. Oxford and AstraZeneca have both defended the integrity of their trials. 

Before news of the delays some capitals were arguing that AstraZeneca should deliver doses even before it receives authorisation from the bloc’s medical regulator. Four countries — Austria, the Czech Republic, Denmark, and Greece — wrote to the European Council president Charles Michel this week to float the idea of “pre-authorisation distribution”, which would allow them to start immunising people the moment approval is received. Danish prime minister Mette Frederiksen pressed the case for early distribution during the Thursday night’s leaders’ talks, people briefed on the call said.

However, the commission raised doubts about such a move, arguing that pharmaceutical companies are likely to be unwilling to shoulder the legal responsibility of releasing the doses before the formal authorisation of the vaccine. 

Posted in International News | Tagged AstraZeneca, delay, delivery, EU, Oxford, vaccine

About the Author

Avatar

Vento

Related Posts

Russian scientists say Sputnik V performs well against COVID mutations→

President of the European Parliament David Sassoli on the pandemic: “There can be no return to how things were before”→

Pfizer vaccine found 94% effective in first big real-world study→

There needs to be a single market for medicinal products so that there is equal access for everyone→

advertisement
  • Posts
  • Comments
  • Tag Cloud
  • Tourism, Hospitality and Travel – Yesterday, Today and Tomorrow

    27th February 2021 / Vento
  • Russian scientists say Sputnik V performs well against COVID mutations

    27th February 2021 / Vento
  • New Arts Education Scheme launched

    27th February 2021 / Vento
  • Saudi Crown prince approved operation against assassinated journalist Jamal Khashoggi: U.S. intelligence

    27th February 2021 / Vento
  • The first published study analysing the profile of social housing applicants

    27th February 2021 / Vento
  • Avatar
    Joseph Tabone on In his final days as POTUS, Trump…Trump will be voted out…
  • Avatar
    Joseph Tabone on Moviment Graffitti in strong opposition to outrageous…Why the objections? If the…
  • Avatar
    Joseph Gatt on The government is committed to supporting Malta’s…Both the Business Start (B…
  • Avatar
    Hindi Lyrics on Nurse death toll from COVID-19 hits the…I have been looking for…
  • Avatar
    Mehfooz Roy on US Presidential Elections: Biden leads polls in…You really think sleepy Joe…
aviation banking Bitcoin blockchain Boris Johnson BOV brexit business China climate change COVID-19 cryptocurrency Donald Trump ECB economy Education environment EU euro area Europe European Commission European Parliament European Union Eurostat eurozone France Germany Government Infrastructure Malta investment Italy lockdown Malta maritime pandemic politics recovery restrictions technology travel UK United States US vaccine WHO

News Calendar

January 2021
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Dec   Feb »
Footer logo
  • Facebook
  • LinkedIn
  • Twitter
 




 
 
 

Copyright © 2016 MaltaWinds.com

Menu

  • About
  • Home